Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
Recruiting
N/A
Interventional Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Male
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 60 (estimated)
- Sponsor
- Nova Scotia Health Authority · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Prostate cancer is the most common cancer diagnosed in men in Canada. Magnetic resonance imaging (MRI) may become a valuable tool to non-invasively identify prostate cancer and assess its biological aggressiveness, which in turn will help doctors make better decisions about how to treat an individual patient's prostate cancer.
Despite the promise of MRI for detecting and characterizing prostate c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
An appropriate diagnostic MRI-P, defined as:
* Being performed on 3T MRI at the Halifax Infirmary Building
* Taken place within 5 weeks of study enrolment
* Having a detectable nodule which anatomically localizes to prostate cancer (PCa) identified in diagnostic biopsy specimen…
Contacts
Dr. Michael Kucharczyk
9024736185
CONTACT